Here are four new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

Gemcitabine hydrochloride injection: Hospira has discontinued manufacturing of its 200 milligram/5.26 milliliter, 1 gram/26.3 milliliter and 2 gram/52.6 milliliter NovaPlus single-dose glass vials of gemcitabine hydrochloride injection, an oncology medication used to treat various cancers.

Ibandronate sodium injection: Apotex and Eugia US have reported a shortage of Ibandronate sodium 1 milligram/milliliter and 3 milliliter prefilled syringes, an intravenous drug used to treat osteoporosis. No reason was provided and supply is intermittent with Apotex estimating resupply by mid-November.

Metyrosine capsules (Demser): Bausch Hea

See Full Page